{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:09:35Z","timestamp":1793329775848,"version":"4.5.0"},"reference-count":60,"publisher":"American Society of Hematology","issue":"8","license":[{"start":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T00:00:00Z","timestamp":1707264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,4,23]]},"abstract":"<jats:sec>\n                  <jats:title>Abstract<\/jats:title>\n                  <jats:p>Primary sinonasal diffuse large B-cell lymphoma (PSDLBCL) is a rare lymphoma with a variable prognosis and a unique relapse\/dissemination pattern involving the central nervous system and skin. The underlying molecular mechanisms leading to this heterogeneity and progression pattern remain uncharted, hampering patient-tailored treatment. To investigate associated mechanisms, we analyzed clinical data and used immunohistochemistry, gene-expression profiling, cytogenetics, and next-generation sequencing in a cohort of 117 patients with PSDLBCL. The distribution in cell-of-origin (COO) was 68 (58%) activated B-cell (ABC), 44 (38%) germinal center B-cell (GCB), and 5 (4%) unclassifiable. COO was significantly associated with progression-free survival (PFS) and lymphoma-specific mortality (LSM) in both the overall cohort (5-year PFS: ABC, 43% vs GCB, 73%; LSM: ABC, 45% vs GCB, 14%) and in the subgroup of patients receiving immunochemotherapy (5-year PFS: ABC, 55% vs GCB, 85%; LSM: ABC, 28% vs GCB, 0%). ABC lymphomas were mainly MCD class, showing a high prevalence of MYD88 (74%) and CD79B (35%) mutations compared with GCB lymphomas (MYD88 23%; CD79B 10%) (P\u00a0&amp;lt; .01). The ABC subtype frequently displayed cMYC\/BCL2 coexpression (76% vs 18% GCB; P\u00a0&amp;lt; .001) and HLA-II loss (48% vs 10% GCB; P\u00a0&amp;lt; .001). PD-L1 expression and copy-number alterations were rare. All lymphomas were Epstein-Barr virus-negative. Our data suggest molecular profiling as a potent tool for detecting prognostic subgroups in PSDLBCL, exposing links to known relapse\/dissemination sites. The ABC subgroup\u2019s MCD genetic features, shared with lymphomas at other nonprofessional lymphoid sites, make them potential candidates for targeted B-cell and toll-like receptor signaling therapy.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1182\/bloodadvances.2023011517","type":"journal-article","created":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T20:04:27Z","timestamp":1707336267000},"page":"1946-1957","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":12,"title":["Sinonasal DLBCL: molecular profiling identifies subtypes with distinctive prognosis and targetable genetic features"],"prefix":"10.1182","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1491-5514","authenticated-orcid":false,"given":"Patrick R. G.","family":"Eriksen","sequence":"first","affiliation":[{"name":"1Department of Otorhinolaryngology, Head and Neck Surgery and Audiology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fleur","family":"de Groot","sequence":"additional","affiliation":[{"name":"2Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Clasen-Linde","sequence":"additional","affiliation":[{"name":"3Department of Pathology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"de Nully Brown","sequence":"additional","affiliation":[{"name":"4Department of Hematology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben","family":"de Groen","sequence":"additional","affiliation":[{"name":"2Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linea C.","family":"Melchior","sequence":"additional","affiliation":[{"name":"3Department of Pathology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5930-0636","authenticated-orcid":false,"given":"Andrea D.","family":"Maier","sequence":"additional","affiliation":[{"name":"5Department of Neurosurgery, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marthe","family":"Minderman","sequence":"additional","affiliation":[{"name":"6Department of Pathology and Cancer Center Amsterdam, Amsterdam University Medical Centers, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1628-6256","authenticated-orcid":false,"given":"Joost S. P.","family":"Vermaat","sequence":"additional","affiliation":[{"name":"2Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6753-8129","authenticated-orcid":false,"given":"Christian","family":"von Buchwald","sequence":"additional","affiliation":[{"name":"1Department of Otorhinolaryngology, Head and Neck Surgery and Audiology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven T.","family":"Pals","sequence":"additional","affiliation":[{"name":"6Department of Pathology and Cancer Center Amsterdam, Amsterdam University Medical Centers, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Heegaard","sequence":"additional","affiliation":[{"name":"7Department of Pathology, Eye Section, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2024,4,12]]},"reference":[{"issue":"8","key":"2024042313310073600_bib1","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s11864-018-0555-8","article-title":"Extranodal diffuse large B cell lymphoma: molecular features, prognosis, and risk of central nervous system recurrence","volume":"19","author":"Ollila","year":"2018","journal-title":"Curr Treat Options Oncol"},{"issue":"8","key":"2024042313310073600_bib2","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1182\/blood.2020007236","article-title":"Genomic subtypes may predict the risk of central nervous system recurrence in diffuse large B-cell lymphoma","volume":"137","author":"Ollila","year":"2020","journal-title":"Blood"},{"key":"2024042313310073600_bib3","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2017","edition":"4th ed."},{"issue":"6769","key":"2024042313310073600_bib4","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"issue":"25","key":"2024042313310073600_bib5","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa012914","article-title":"The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma","volume":"346","author":"Rosenwald","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"2024042313310073600_bib6","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ccell.2020.03.015","article-title":"A\u00a0probabilistic classification tool for genetic subtypes of diffuse large B cell lymphoma with therapeutic implications","volume":"37","author":"Wright","year":"2020","journal-title":"Cancer Cell"},{"issue":"5","key":"2024042313310073600_bib7","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","article-title":"Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes","volume":"24","author":"Chapuy","year":"2018","journal-title":"Nat Med"},{"issue":"15","key":"2024042313310073600_bib8","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","article-title":"Genetics and pathogenesis of diffuse large B-cell lymphoma","volume":"378","author":"Schmitz","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"2024042313310073600_bib9","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1007\/s00277-017-3094-7","article-title":"Patients with primary breast and primary female genital tract diffuse large B cell lymphoma have a high frequency of MYD88 and CD79B mutations","volume":"96","author":"Cao","year":"2017","journal-title":"Ann Hematol"},{"issue":"11","key":"2024042313310073600_bib10","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1016\/j.jid.2019.05.008","article-title":"Mutations of the B-cell receptor pathway confer chemoresistance in primary cutaneous diffuse large B-cell lymphoma leg type","volume":"139","author":"Ducharme","year":"2019","journal-title":"J\u00a0Invest Dermatol"},{"issue":"9","key":"2024042313310073600_bib11","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1016\/j.jid.2017.04.010","article-title":"Identification of somatic mutations in primary cutaneous diffuse large B-cell lymphoma, leg type by massive parallel sequencing","volume":"137","author":"Mareschal","year":"2017","journal-title":"J\u00a0Invest Dermatol"},{"issue":"13","key":"2024042313310073600_bib12","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1182\/blood.2021011366","article-title":"Immune evasion in primary testicular and central nervous system lymphomas: HLA loss rather than 9p24.1\/PD-L1\/PD-L2 alterations","volume":"138","author":"Minderman","year":"2021","journal-title":"Blood"},{"issue":"9","key":"2024042313310073600_bib13","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1038\/bcj.2013.28","article-title":"High prevalence of oncogenic MYD88 and CD79B mutations in diffuse large B-cell lymphomas presenting at immune-privileged sites","volume":"3","author":"Kraan","year":"2013","journal-title":"Blood Cancer J"},{"issue":"2","key":"2024042313310073600_bib14","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/ejh.13191","article-title":"CD79B mutations in primary vitreoretinal lymphoma: diagnostic and prognostic potential","volume":"102","author":"Yonese","year":"2019","journal-title":"Eur J Haematol"},{"issue":"3","key":"2024042313310073600_bib15","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/leu.2013.348","article-title":"High prevalence of oncogenic MYD88 and CD79B mutations in primary testicular diffuse large B-cell lymphoma","volume":"28","author":"Kraan","year":"2014","journal-title":"Leukemia"},{"issue":"2","key":"2024042313310073600_bib16","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/bjh.14392","article-title":"Diffuse large B-cell lymphoma with testicular involvement: outcome and risk of CNS relapse in the rituximab era","volume":"176","author":"Kridel","year":"2016","journal-title":"Br J Haematol"},{"issue":"3","key":"2024042313310073600_bib17","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/bjh.12753","article-title":"A\u00a0multicentre study of primary breast diffuse large B-cell lymphoma in the rituximab era","volume":"165","author":"Hosein","year":"2014","journal-title":"Br J Haematol"},{"issue":"1","key":"2024042313310073600_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-10-321","article-title":"Clinical outcomes and prognostic factors in patients with breast diffuse large B cell lymphoma; Consortium for Improving Survival of Lymphoma (CISL) study","volume":"10","author":"Yhim","year":"2010","journal-title":"BMC Cancer"},{"issue":"pt 3","key":"2024042313310073600_bib19","first-page":"657","article-title":"Histology of the human nasopharyngeal mucosa","volume":"99","author":"Ali","year":"1965","journal-title":"J\u00a0Anat"},{"issue":"4","key":"2024042313310073600_bib20","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s00432-020-03421-5","article-title":"Major driver mutations are shared between sinonasal intestinal-type adenocarcinoma and the morphologically identical colorectal adenocarcinoma","volume":"147","author":"Sj\u00f6stedt","year":"2021","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"issue":"suppl S29","key":"2024042313310073600_bib21","first-page":"1","article-title":"European position paper on rhinosinusitis and nasal polyps 2020","volume":"58","author":"Fokkens","year":"2020","journal-title":"Rhinology"},{"issue":"11","key":"2024042313310073600_bib22","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1080\/10428194.2022.2087069","article-title":"NK- and T-cell lymphoma of the nasal cavity and paranasal sinuses in Denmark 1980-2017: a nationwide cohort study","volume":"63","author":"Eriksen","year":"2022","journal-title":"Leuk Lymphoma"},{"issue":"11","key":"2024042313310073600_bib23","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1002\/(SICI)1097-0142(19990601)85:11<2305::AID-CNCR2>3.0.CO;2-3","article-title":"Extramedullary plasmacytoma","volume":"85","author":"Alexiou","year":"1999","journal-title":"Cancer"},{"issue":"2","key":"2024042313310073600_bib24","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/hon.2968","article-title":"Sinonasal B-cell lymphomas: a nationwide cohort study, with an emphasis on the prognosis and the recurrence pattern of primary diffuse large B-cell lymphoma","volume":"40","author":"Eriksen","year":"2022","journal-title":"Hematol Oncol"},{"issue":"1","key":"2024042313310073600_bib25","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"issue":"8","key":"2024042313310073600_bib26","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1182\/blood-2013-11-536433","article-title":"Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue","volume":"123","author":"Scott","year":"2014","journal-title":"Blood"},{"issue":"19","key":"2024042313310073600_bib27","first-page":"3760","article-title":"Frequent mutated B2M , EZH2 , IRF8 , and TNFRSF14 in primary bone diffuse large B-cell lymphoma reflect a GCB phenotype","volume":"5","author":"de Groen","year":"2021","journal-title":"Blood Adv"},{"issue":"5","key":"2024042313310073600_bib28","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1080\/10428194.2021.2015589","article-title":"Synchronous diffuse large B-cell lymphoma and mantle cell lymphoma: support for low-threshold biopsies and genetic testing","volume":"63","author":"Groot","year":"2021","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"2024042313310073600_bib29","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41392-023-01358-y","article-title":"Simplified algorithm for genetic subtyping in diffuse large B-cell lymphoma","volume":"8","author":"Shen","year":"2023","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"2024042313310073600_bib30","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1038\/s41598-020-80376-0","article-title":"Proposal and validation of a method to classify genetic subtypes of diffuse large B cell lymphoma","volume":"11","author":"Pedrosa","year":"2021","journal-title":"Sci Rep"},{"issue":"20","key":"2024042313310073600_bib31","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1182\/blood.2019003535","article-title":"Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report","volume":"135","author":"Lacy","year":"2020","journal-title":"Blood"},{"issue":"18","key":"2024042313310073600_bib32","first-page":"2182","article-title":"Impact of dual expression of MYC and BCL2 by immunohistochemistry on the risk of CNS relapse in DLBCL","volume":"127","author":"Savage","year":"2016","journal-title":"Blood J Am Soc Hematol"},{"key":"2024042313310073600_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2021.01.006","article-title":"Double expressor and double\/triple hit status among primary cutaneous diffuse large B-cell lymphoma: a comparison between leg type and not otherwise specified subtypes","volume":"111","author":"Lucioni","year":"2021","journal-title":"Hum Pathol"},{"issue":"45","key":"2024042313310073600_bib34","doi-asserted-by":"crossref","first-page":"e17827","DOI":"10.1097\/MD.0000000000017827","article-title":"Immunohistochemical overexpression of BCL-2 protein predicts an inferior survival in patients with primary central nervous system diffuse large B-cell lymphoma","volume":"98","author":"Chen","year":"2019","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"2024042313310073600_bib35","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00401-013-1169-7","article-title":"Frequent triple-hit expression of MYC, BCL2, and BCL6 in primary lymphoma of the central nervous system and absence of a favorable MYClowBCL2low subgroup may underlie the inferior prognosis as compared to systemic diffuse large B cell lymphomas","volume":"126","author":"Brunn","year":"2013","journal-title":"Acta Neuropathol (Berl)"},{"issue":"11","key":"2024042313310073600_bib36","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1097\/PAS.0000000000001132","article-title":"High incidence and clinical significance of MYC rearrangements in primary cutaneous diffuse large B-cell lymphoma, leg type","volume":"42","author":"Schrader","year":"2018","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"2024042313310073600_bib37","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.cell.2017.09.027","article-title":"Genetic and functional drivers of diffuse large B cell lymphoma","volume":"171","author":"Reddy","year":"2017","journal-title":"Cell"},{"issue":"12","key":"2024042313310073600_bib38","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.ccell.2021.10.006","article-title":"Effect of ibrutinib with R-CHOP chemotherapy in genetic subtypes of DLBCL","volume":"39","author":"Wilson","year":"2021","journal-title":"Cancer Cell"},{"issue":"8","key":"2024042313310073600_bib39","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.3324\/haematol.2017.184192","article-title":"Hide or defend, the two strategies of lymphoma immune evasion: potential implications for immunotherapy","volume":"103","author":"de Charette","year":"2018","journal-title":"Haematologica"},{"issue":"10","key":"2024042313310073600_bib40","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1182\/blood-2011-05-326538","article-title":"The molecular pathogenesis of primary mediastinal large B-cell lymphoma","volume":"118","author":"Steidl","year":"2011","journal-title":"Blood"},{"issue":"17","key":"2024042313310073600_bib41","first-page":"3268","article-title":"Integrative analysis reveals selective 9p24. 1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma","volume":"116","author":"Green","year":"2010","journal-title":"Blood J Am Soc Hematol"},{"issue":"6","key":"2024042313310073600_bib42","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/ejh.13225","article-title":"Clinical features and outcome of the patients with sinonasal tract diffuse large B-cell lymphoma in the pre-rituximab and rituximab eras","volume":"102","author":"V\u00e4h\u00e4murto","year":"2019","journal-title":"Eur J Haematol"},{"issue":"18","key":"2024042313310073600_bib43","first-page":"4836","article-title":"Gene-expression profiling and not immunophenotypic algorithms predicts prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy","volume":"117","author":"Guti\u00e9rrez-Garc\u00eda","year":"2011","journal-title":"Blood J Am Soc Hematol"},{"issue":"26","key":"2024042313310073600_bib44","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1200\/JCO.2014.60.2383","article-title":"Prognostic significance of diffuse large B-cell lymphoma cell of origin determined by digital gene expression in formalin-fixed paraffin-embedded tissue biopsies","volume":"33","author":"Scott","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"22","key":"2024042313310073600_bib45","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1056\/NEJMoa0802885","article-title":"Stromal gene signatures in large-B-cell lymphomas","volume":"359","author":"Lenz","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"14","key":"2024042313310073600_bib46","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1182\/bloodadvances.2020001949","article-title":"A\u00a0refined cell-of-origin classifier with targeted NGS and artificial intelligence shows robust predictive value in DLBCL","volume":"4","author":"Xu-Monette","year":"2020","journal-title":"Blood Adv"},{"issue":"20","key":"2024042313310073600_bib47","doi-asserted-by":"crossref","first-page":"5152","DOI":"10.3390\/cancers14205152","article-title":"Genetic stability of driver alterations in primary cutaneous diffuse large B-cell lymphoma, leg type and their relapses: a rationale for the use of molecular-based methods for more effective disease monitoring","volume":"14","author":"Schrader","year":"2022","journal-title":"Cancers"},{"issue":"7718","key":"2024042313310073600_bib48","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41586-018-0290-0","article-title":"A\u00a0multiprotein supercomplex controlling oncogenic signalling in lymphoma","volume":"560","author":"Phelan","year":"2018","journal-title":"Nature"},{"key":"2024042313310073600_bib49","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.2147\/JIR.S341355","article-title":"The mutation of BTG2 gene predicts a poor outcome in primary testicular diffuse large B-cell lymphoma","volume":"15","author":"Guo","year":"2022","journal-title":"J\u00a0Inflamm Res"},{"issue":"20","key":"2024042313310073600_bib50","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1182\/blood.2020005857","article-title":"The dangers of d\u00e9j\u00e0 vu: memory B cells as the cells of origin of ABC-DLBCLs","volume":"136","author":"Venturutti","year":"2020","journal-title":"Blood"},{"issue":"6","key":"2024042313310073600_bib51","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.cell.2010.08.031","article-title":"Natural killer cell education and tolerance","volume":"142","author":"Orr","year":"2010","journal-title":"Cell"},{"key":"2024042313310073600_bib52","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/B978-0-12-370454-2.00028-4","article-title":"Nature killer cells in the central nervous system","author":"Shi","year":"2010","journal-title":"Natural Killer Cells"},{"issue":"1","key":"2024042313310073600_bib53","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1465-9921-12-102","article-title":"Nasal lavage natural killer cell function is suppressed in smokers after live attenuated influenza virus","volume":"12","author":"Horvath","year":"2011","journal-title":"Respir Res"},{"issue":"10","key":"2024042313310073600_bib54","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1182\/blood.V96.10.3569","article-title":"Extensive genetic alterations of the HLA region, including homozygous deletions of HLA class II genes in B-cell lymphomas arising in immune-privileged sites","volume":"96","author":"Riemersma","year":"2000","journal-title":"Blood"},{"issue":"11","key":"2024042313310073600_bib55","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.1182\/blood-2003-07-2365","article-title":"Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project","volume":"103","author":"Rimsza","year":"2004","journal-title":"Blood"},{"issue":"4","key":"2024042313310073600_bib56","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1158\/2159-8290.CD-18-1090","article-title":"Molecular and genetic characterization of MHC deficiency identifies EZH2 as therapeutic target for enhancing immune recognition","volume":"9","author":"Ennishi","year":"2019","journal-title":"Cancer Discov"},{"issue":"7","key":"2024042313310073600_bib57","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1182\/blood-2015-10-673236","article-title":"Targetable genetic features of primary testicular and primary central nervous system lymphomas","volume":"127","author":"Chapuy","year":"2016","journal-title":"Blood"},{"issue":"1","key":"2024042313310073600_bib58","doi-asserted-by":"crossref","first-page":"42","DOI":"10.5414\/NP300698","article-title":"PD1 (CD279) and PD-L1 (CD274, B7H1) expression in primary central nervous system lymphomas (PCNSL)","volume":"33","author":"Berghoff","year":"2014","journal-title":"Clin Neuropathol"},{"issue":"1","key":"2024042313310073600_bib59","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s12885-020-06755-y","article-title":"PD-L1 and PD-L2 expression in the tumor microenvironment including peritumoral tissue in primary central nervous system lymphoma","volume":"20","author":"Furuse","year":"2020","journal-title":"BMC Cancer"},{"issue":"10","key":"2024042313310073600_bib60","first-page":"5655","article-title":"Programmed cell death ligand 1 expression in primary central nervous system lymphomas: a clinicopathological study","volume":"37","author":"Hayano","year":"2017","journal-title":"Anticancer Res"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/8\/1946\/2222835\/blooda_adv-2023-011517-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/8\/1946\/2222835\/blooda_adv-2023-011517-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T13:31:39Z","timestamp":1713879099000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/8\/8\/1946\/514841\/Sinonasal-DLBCL-molecular-profiling-identifies"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,12]]},"references-count":60,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,4,23]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2023011517","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,12]]}}}